Published in Can Fam Physician on August 01, 2012
Rate versus rhythm control in atrial fibrillation. Can Fam Physician (2013) 0.86
Warfarin: its highs and lows. Can Fam Physician (2013) 0.75
Quality, accountability, and transparency. Can Fam Physician (2012) 0.75
Canadian trial data? Can Fam Physician (2012) 0.75
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med (2007) 10.87
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med (2009) 4.71
Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation (2012) 3.47
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol (2012) 2.96
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol (2011) 2.48
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol (2012) 2.41
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost (2012) 1.78
Rate versus rhythm control in atrial fibrillation. Can Fam Physician (2013) 0.86
Taking the stress out of acne management. Can Fam Physician (2009) 0.83
A brief overview of academic detailing in Canada: Another role for pharmacists. Can Pharm J (Ott) (2012) 0.82
Approach to the management of idiopathic hirsutism. Can Fam Physician (2012) 0.75
Targeting success in heart failure: evidence-based management. Can Fam Physician (2010) 0.75
Warfarin: its highs and lows. Can Fam Physician (2013) 0.75
Funding for continuing medical education. CMAJ (2008) 0.75